New FDA-Cleared Microbroth Dilution Susceptibility Testing Plate Expands Patient Treatment Options for Gram Negative Infections

New antimicrobial options, including ceftolozane/tazobactam and ceftazidime/avibactam, and extended dilution ranges enable targeted treatment recommendations (PRNewsfoto/Thermo Fisher Scientific Inc.) EAST GRINSTEAD, England, June 29, 2017 /PRNewswire/ — A new FDA-cleared microbroth dilution plate for antimicrobial susceptibility (AST) of Gram negative organisms is now available in the U.S., including two of the latest novel compounds, ceftolozane/tazobactam and ceftazidime/avibactam. The... Read more

Thermo Fisher Scientific Adds Three New Products to Leading Semiconductor Portfolio

New products designed to help semiconductor failure analysis labs achieve higher volumes of samples and faster time-to-data HILLSBORO, Ore., June 29, 2017 /PRNewswire/ — For semiconductor manufacturers seeking fast, high-quality electrical and physical failure analysis, Thermo Fisher Scientific today announced three new additions to its broad portfolio of semiconductor failure analysis workflows. The company will demonstrate these products and... Read more

Gyros Protein Technologies introduces new ADA solution for immunogenicity market

Developed to support assay development and validation for detection of anti-drug antibodies   Uppsala, Sweden, June 29th, 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market.  ... Read more

New Prep-4388 Preparative SFC System

By John Burchell / June 29, 2017 Prep-4388 Preparative SFC System The all new Prep-4388 preparative SFC system includes many new features, such as mass directed prep using a single quad MS detector, a higher flow rate pump with increased pressure limit for 3cm columns and increased productivity. Automated CO2 shutoff valves for easy priming and to prevent backflow... Read more

Thermo Fisher Scientific Announces Availability of Two New Immunoassays Designed to Maximize Detection of Synthetic Cannabinoids

FREMONT, Calif., June 28, 2017 /PRNewswire/ — Two new immunoassays for the detection of Synthetic Cannabinoids, the Thermo Fisher CEDIA AB-PINACA and CEDIA UR-144/XLR11 Assays are now available for Criminal Justice and Forensic Use.  Synthetic Cannabinoids are the largest and fastest growing group of new psychoactive substances on the market, making the availability of these assays... Read more

908 Devices Launches 3-in-1 GC-HPMS Analyzer to Increase Quality and Efficiency Throughout Cannabis Production and Testing Industries

06.27.17 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced the introduction of the G908™ 3-in-1 Cannabis Analyzer. This innovative device combines the Company’s patented and award-winning high-pressure mass spectrometry™ (HPMS) technology with the separating power of ballistic gas chromatography (GC), enabling customers throughout the cannabis testing industry to perform three... Read more

Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)

Basel, 27 June 2017 Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of Esbriet offers a reduced pill burden for patients with idiopathic pulmonary fibrosis (IPF) People with IPF now have the option of taking one Esbriet... Read more

Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF)

Basel, 27 June 2017 Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF) New immediate-release tablet formulation of Esbriet offers a reduced pill burden for patients with idiopathic pulmonary fibrosis (IPF) People with IPF now have the option of taking one Esbriet... Read more

DNAnexus Launches Novel Platform for Human Microbiome Research

Community-driven platform to advance microbiome bioinformatics and standards through global research and collaboration June 27, 2017 08:00 AM Eastern Daylight Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, Inc., the global leader in genome informatics and data management, today announced the launch of the MOSAIC Microbiome Platform in collaboration with Janssen Research & Development, LLC and its Janssen... Read more